CDER: 312 Subpart F - Miscellaneous provisions including import & export requirements and foreign clinical studies and issuance of guidance to help comply with regulatory requirements (312.145)

Investigational New Drug Regulations

ICH Guidance - Good Clinical Practice March 2018

CDER: 312 Subpart F - Miscellaneous provisions including import & export requirements and foreign clinical studies and issuance of guidance to help comply with regulatory requirements (312.145)

OMB: 0910-0014

Document [file]
Download: file | pdf

© 2024 OMB.report | Privacy Policy